WHO dismisses Paracetamol Autism Link

WHO Rejects Claims Linking Paracetamol Use in Pregnancy to Autism

BRUSSELS – The World Health Organization (WHO) announced on Wednesday that no scientific evidence proves a link between autism and the use of paracetamol during pregnancy, directly rejecting recent claims by US President Donald Trump.

Autism Prevalence and Causes

According to WHO, nearly 62 million people worldwide live with autism spectrum disorder (ASD), which affects brain development. This means roughly one in every 127 people is on the spectrum. While awareness and diagnosis have improved in recent years, the exact causes of autism remain uncertain, with researchers pointing to a combination of factors.

Trump’s Claim

On Monday, Trump claimed that using Tylenol—commonly known as paracetamol—during pregnancy could “significantly” increase the risk of autism. His statement quickly drew global attention and concern.

WHO’s Response

WHO emphasized that more than a decade of scientific research, including multiple large-scale studies, has found no consistent evidence linking prenatal paracetamol use to autism. The agency stressed that medical guidance should remain the basis for decisions about drug use during pregnancy.

Vaccines Not Linked to Autism

The organization also restated that childhood vaccines do not cause autism. Evidence from numerous studies in different countries has disproved claims of a connection, including those involving thiomersal and aluminum.

WHO Chief’s Guidance

WHO Director-General Tedros Adhanom Ghebreyesus, posting on X, urged pregnant women to follow professional medical advice. He noted that caution is always important when taking any medication, especially during the first trimester.
NEWS DESK 
PRESS UPDATE